These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26021176)

  • 21. A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management.
    Shatnawi A; Latif DA
    J Eval Clin Pract; 2017 Jun; 23(3):586-592. PubMed ID: 27882650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Information transmission to the community pharmacist after a patient's discharge from the hospital: setting up of a written medication discharge form, prospective evaluation of its impact, and survey of the information needs of the pharmacists].
    Claeys C; Dufrasne M; De Vriese C; Nève J; Tulkens PM; Spinewine A
    J Pharm Belg; 2015 Mar; (1):42-54. PubMed ID: 26571796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication management in Minnesota schools: The need for school nurse-pharmacist partnerships.
    Little MM; Eischens S; Martin MJ; Nokleby S; Palombi LC; Van Kirk C; van Risseghem J; Wen YF; Wozniak JK; Yoney E; Seifert R
    J Am Pharm Assoc (2003); 2018; 58(1):67-72.e1. PubMed ID: 29128237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team.
    Cappelletty D; Jacobs D
    Am J Health Syst Pharm; 2013 Jun; 70(12):1065-9. PubMed ID: 23719885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidisciplinary teams involved: detection of drug-related problems through continuity of care.
    Romero-Ventosa EY; Samartín-Ucha M; Martín-Vila A; Martínez-Sánchez ML; Rey Gómez-Serranillos I; Pineiro-Corrales G
    Farm Hosp; 2016 Nov; 40(n06):529-543. PubMed ID: 27894227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of a pharmacist in improving rational drug therapy as part of the patient care team.
    Smith WE
    Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist Role in Transitions of Care.
    Consult Pharm; 2017 Oct; 32(10):645-649. PubMed ID: 28992825
    [No Abstract]   [Full Text] [Related]  

  • 31. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
    Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
    Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a comprehensive pharmacist medication-therapy management service.
    Shaya FT; Chirikov VV; Rochester C; Zaghab RW; Kucharski KC
    J Med Econ; 2015; 18(10):828-37. PubMed ID: 25985395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication management during pregnancy: role of the pharmacist.
    Samuel N; Einarson A
    Int J Clin Pharm; 2011 Dec; 33(6):882-5. PubMed ID: 21915759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical home 101: the pharmacist's role in this growing patient-centered care model.
    Kaldy J
    Consult Pharm; 2010 Aug; 25(8):468-74. PubMed ID: 20736156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process indicators of quality clinical pharmacy services during transitions of care.
    ; Kirwin J; Canales AE; Bentley ML; Bungay K; Chan T; Dobson E; Holder RM; Johnson D; Lilliston A; Mohammad RA; Spinler SA
    Pharmacotherapy; 2012 Nov; 32(11):e338-47. PubMed ID: 23108762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating pharmacists into primary care teams: barriers and facilitators.
    Jorgenson D; Laubscher T; Lyons B; Palmer R
    Int J Pharm Pract; 2014 Aug; 22(4):292-9. PubMed ID: 24279947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicians' perspectives on clinical pharmacy services in Northern Sweden: a qualitative study.
    Vinterflod C; Gustafsson M; Mattsson S; Gallego G
    BMC Health Serv Res; 2018 Jan; 18(1):35. PubMed ID: 29361941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
    Luder HR; Frede SM; Kirby JA; Epplen K; Cavanaugh T; Martin-Boone JE; Conrad WF; Kuhlmann D; Heaton PC
    J Am Pharm Assoc (2003); 2015; 55(3):246-54. PubMed ID: 26003155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.